A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06249919 |
|
Recruitment Status :
Recruiting
First Posted : February 8, 2024
Last Update Posted : February 8, 2024
|
Sponsor:
Neuracle Science Co., LTD.
Collaborators:
Severance Hospital
Samsung Medical Center
Korea University Anam Hospital
Information provided by (Responsible Party):
Neuracle Science Co., LTD.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 19, 2025 |
| Estimated Study Completion Date : | June 19, 2025 |